Convalescent Plasma to Limit SARS-CoV-2 Associated Complications

NCT04373460 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
1225
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Johns Hopkins University

Collaborators